Research Use Only · COA Available · Authorized Researchers

Research Updates

Research Briefings

In-depth breakdowns of the compounds we carry — mechanisms, applications, and the research behind them.

Mechanism breakdownsPeer-reviewed sourcesCOA-backed
Research Use Only
COA-Focused Context
Educational Updates

Latest Articles

Latest Research Briefings

View catalog →
Neuropeptide Research ReferenceSeptember 1, 20268 min read

Nootropic Peptides: The Research on Memory, Focus, and Stress Resilience

A research reference on the neuropeptides studied for cognition — how Semax, Selank, Cerebrolysin, and Dihexa act on BDNF, GABA-A signalling, neurotrophic support, and synaptogenesis, and where the evidence for each actually sits.

BDNF

Semax upregulates brain-derived neurotrophic factor, central to long-term potentiation

GABA-A

Selank modulates GABA-A and serotonin signalling without the sedation of anxiolytics

c-Met

Dihexa potentiates hepatocyte growth factor to drive synaptogenesis

Ion Channel Research ReferenceAugust 25, 20268 min read

TREK-1: The Leak Channel Researchers Push in Both Directions

A research reference on the TREK-1 two-pore-domain potassium channel (KCNK2) — how polymodal gating works, and why the literature blocks the channel for neurogenesis endpoints while opening it for excitotoxicity endpoints.

KCNK2

The gene encoding TREK-1, a member of the two-pore-domain (K2P) family

Polymodal

Gated by membrane stretch, intracellular acidosis, and polyunsaturated lipids

Bidirectional

Blockers are studied for neurogenesis; openers for ischemic protection

Multi-Organ Research ReferenceAugust 25, 20269 min read

Triple-Organ Protection: Seven Compounds Studied Across Brain, Kidney, and Heart

A research reference on multi-organ protection — how the literature characterizes glutathione, NAC, SS-31, KPV, NAD+, L-Carnitine, and PE-22-28 across neural, renal, and cardiac models, and why the three most metabolically expensive organ systems share a single failure sequence.

ROS

Oxidative load is the shared failure mode across all three organ systems

Cardiolipin

SS-31 binds the inner mitochondrial membrane to preserve cristae architecture

SIRT1/3

NAD+ availability gates sirtuin-mediated cellular stress resistance

Metabolic Research ReferenceJuly 21, 20266 min read

The Lean Mass Preservation Protocol: Fat Loss Without Muscle Wasting

A research reference on body-composition partitioning — how the literature characterizes HGH, AOD9604, Tesamorelin, and MOTS-c for targeted lipolysis and lean-tissue preservation during a caloric deficit, alongside the nutritional substrates studied for anti-catabolic support.

IGF-1

GH-driven IGF-1 and mTOR signaling associated with lean-tissue preservation

β3

AOD9604 stimulates lipolysis via β3-adrenergic receptors without IGF-1 binding

AMPK

MOTS-c activates AMPK to oxidize freed fatty acids

Neuropeptide Research ReferenceJuly 16, 20266 min read

VIP: A Systemic Research Profile of Vasoactive Intestinal Peptide

Vasoactive Intestinal Peptide (VIP) is a 28-amino-acid neuropeptide studied as a systemic 'repair and relax' signal — spanning immune modulation, airway and pulmonary research, metabolic regulation, and circadian control. A research reference on the mechanism, the systems it acts on, and the literature behind them.

28-aa

Amino-acid neuropeptide of the secretin/glucagon family

VPAC1/2

Class B GPCR receptors it binds to drive cAMP signaling

4 systems

Immune, respiratory, metabolic, and circadian research domains

Skin & Tissue Research ReferenceJuly 10, 20266 min read

The Architecture of Facial Quality: A Science-Based Approach

Building resilient, youthful-looking skin is a pursuit of structural integrity — nutrition, induction, and preservation. A research reference on the biology of collagen: the raw materials, the signals that drive synthesis (including GHK-Cu), and the defenses that prevent breakdown.

Build

Nutritional foundation — amino acids and Vitamin C as collagen raw materials

Induce

Micro-needling and GHK-Cu signaling to activate fibroblasts

Preserve

UV protection and glycation control to stop collagen breakdown

Vascular Research ReferenceJuly 10, 20266 min read

Tadalafil: A Systemic Vascular and Metabolic Research Profile

A research reference on tadalafil (Cialis) — a PDE5 inhibitor studied for endothelial function, prostatic/urinary health, exercise capacity, and metabolic context. Mechanism via the nitric oxide / cGMP pathway, applications, dosing considerations, risks, and a full medical disclaimer.

PDE5

Selectively inhibits the PDE5 enzyme to preserve cGMP

~17.5 hr

Long terminal half-life — a therapeutic window up to 36 hours

NO pathway

Promotes vasodilation and increased systemic blood flow

Hormone Research ReferenceJuly 10, 20265 min read

Stimulating the Body's Own Pathways: Clomiphene (Clomid) as a SERM in Male Hormone Research

A research reference on clomiphene citrate (Clomid) — a Selective Estrogen Receptor Modulator studied off-label for male hormone optimization. How it manipulates estrogen feedback to raise LH and FSH, the applications in male health, and a full medical disclaimer.

SERM

Selective Estrogen Receptor Modulator — manipulates estrogen feedback

LH + FSH

Raises gonadotropins to stimulate endogenous testosterone and spermatogenesis

Off-label

Not FDA-approved for men — used off-label; research/educational reference

Metabolic Research ReferenceJune 20, 20267 min read

Optimizing Metabolic Signaling: The Synergy of 5-Amino-1MQ and GLP-1 Receptor Agonists

A deep dive into why researchers are pairing 5-Amino-1MQ (an NNMT inhibitor that preserves NAD+) with GLP-1 receptor agonists like semaglutide and tirzepatide — two distinct pathways: incretin-driven intake control and cellular-level metabolic output. Mechanisms, the proposed synergy, considerations, and a full medical disclaimer.

NNMT

5-Amino-1MQ inhibits nicotinamide N-methyltransferase to preserve NAD+

Intake + output

GLP-1s control caloric intake; 5-Amino-1MQ supports metabolic output

RUO

5-Amino-1MQ is a research chemical — not FDA-evaluated; research use only

Metabolic Research ReferenceJune 18, 20268 min read

SLU-PP-332: A Pan-ERR Agonist for Metabolic and Exercise-Physiology Research

SLU-PP-332 is a synthetic small-molecule agonist of all three estrogen-related receptors (ERRα/β/γ), studied as a tool for oxidative metabolism, mitochondrial function, and the molecular basis of exercise adaptation. A research reference: chemical profile, mechanism, preclinical findings, regulatory status, handling, and analytical methods. Ships for laboratory research use only.

ERRα/β/γ

Pan-ERR agonist — activates all three estrogen-related receptor isoforms

~400 nM

Approximate EC50 at each ERR isoform

RUO

Investigational — not FDA-approved; laboratory research use only

Metabolic Research Deep DiveJune 13, 20267 min read

L-Carnitine: The Underrated Fat-Metabolism Nutrient With Heart-Health Research Behind It

L-carnitine gets sold as a "fat burner," but the real story is more interesting. A research-grade look at the mitochondrial fatty-acid shuttle, the Mayo Clinic Proceedings post-MI meta-analysis, what the body-composition trials actually show, and how to frame the cardiovascular data without overstating it.

−27%

All-cause mortality vs control in a post-heart-attack meta-analysis (Mayo Clinic Proceedings, 2013)

37 RCTs

A 2020 meta-analysis found reduced body weight, BMI, and fat mass — strongest in overweight/obese adults

~1.33 kg

Average extra weight lost vs placebo in a separate 2016 meta-analysis

Metabolic Research ComparisonMay 22, 20265 min read

Mazdutide vs. Survodutide: The Next Wave of Dual GLP-1 / Glucagon Agonists

A side-by-side of the two highest-profile dual GLP-1 / glucagon agonists currently in late-stage clinical development. Mechanism, weight-loss + MASH data, and where each one is the better candidate. Plus a Memorial Day weekend sale: 20% off everything with code MEMORIAL20.

20% off

Memorial Day weekend — code MEMORIAL20 at checkout (ends Mon May 26)

~40%

Survodutide trial participants losing >20% baseline weight

MASH

Survodutide's distinguishing edge: histological liver-fibrosis improvement

Immunopeptide Deep DiveMay 23, 20265 min read

Thymalin: The Russian Immunopeptide With 40+ Years of T-Cell Research

Thymalin is a thymus-derived polypeptide complex approved as an immunomodulator in the former Soviet Union in 1982 and still actively studied in Russian and Eastern European clinical literature. A research-tool deep dive on the T-cell differentiation mechanism, the cytokine-storm modulation work that re-surfaced during the COVID era, and where it sits in the regulatory landscape.

1982

Approved as an immunomodulator in the former Soviet Union

T-cell

Primary mechanism: hematopoietic stem cell → mature T-lymphocyte differentiation

Cytokine

Re-examined during COVID-19 as a cytokine-storm modulator

Metabolic ResearchMay 21, 20265 min read

Adipotide: A Vascular-Targeted Approach to Fat Loss

Adipotide is a peptidomimetic that disrupts the blood supply to white adipose tissue rather than acting through hunger or hormone pathways. A research-tool deep dive on the mechanism, what the primate data showed, and the renal-toxicity profile that's kept it out of clinical use.

Vascular

Targets the endothelium of white-fat blood supply, not the brain

Renal

Dose-dependent kidney toxicity is the headline safety signal

Primate

Strongest published data set is in obese rhesus macaque models

Neuropeptide Deep DiveMay 19, 20266 min read

PE-22-28: A Dark Horse in Mood Regulation and Neuropharmacology

PE-22-28 is a sortilin-derived heptapeptide and one of the most selective TREK-1 potassium-channel inhibitors known. A deep dive on the mechanism, the research applications across neurogenesis and stress resilience, and what distinguishes it from SSRI-class antidepressants.

GVSWGLR

7-amino-acid sequence — a truncated, optimized spadin fragment

TREK-1

Highly selective inhibition of the two-pore-domain K+ channel

Hours

Onset of measurable antidepressant-like effects in preclinical models

New ArrivalsMay 17, 20264 min read

May 2026 New Arrivals: Senolytics, Adipose-Targeted Peptides, Thymalin, PE-228, and Oral 5-Amino-1MQ

Five new research compounds added to the Revitalized catalog this week — FOX04-DRI, Adiapoptide, Thymalin, PE-228, and an oral capsule formulation of 5-Amino-1MQ. Brief mechanism summaries and where each one fits.

5

New SKUs added to the catalog this week

$65–$110

Single-vial price range across the new peptide additions

1

First oral capsule version of an existing peptide vial

Peptide Research ReportMay 5, 20268 min read

The Great Compounding Reversal, CagriSema's Report Card, and the May 2026 Cardiometabolic Pipeline

The February 2026 HHS reversal restores Category 1 access for BPC-157, Thymosin Alpha-1, CJC-1295, and MOTS-c. Plus the latest data on CagriSema, Survodutide, MariTide, Mazdutide, and the emerging Picobody and Graspetide classes.

14–19

Peptides being restored to Category 1 status by HHS

23%

CagriSema 84-week weight loss in REDEFINE-4 Phase III

18.6%

Mazdutide placebo-adjusted weight reduction in MED Journal data